Webinar: COVID-19 Vaccines: How did we get here and where are we going? - POCTRN
Center news
Webinar: COVID-19 Vaccines: How did we get here and where are we going?
Please join us as we review how the currently available COVID-19 vaccines were developed and the evaluation process that led to their emergency use authorizations.
Please join us as we review how the currently available COVID-19 vaccines were developed and the evaluation process that led to their emergency use authorizations. We will also touch upon the expected side effects, the timelines for full approval of the vaccines for adults, and the landscape for use in children. Lastly, we will discuss what we know about the effectiveness of the vaccines against the COVID-19 variants.
Speaker
Anna P. Durbin, MD
Professor, International Health at the Johns Hopkins Bloomberg School of Public Health
When
June 1, 2021
2PM, ET
Watch the Recording >
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness